Endekay

Quick links to important sections

Medically reviewed

Marina Burgos

Last updated on 10/01/2026

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Endekay

What is Endekay?

Endekay is a range of dental health products primarily focused on the prevention of dental caries (tooth decay) and the maintenance of oral hygiene. These products are formulated to strengthen tooth enamel and provide protection against the acid-producing bacteria found in dental plaque.

Therapeutic Purpose

The primary therapeutic goal of Endekay products is to deliver fluoride to the surface of the teeth. Fluoride is a mineral that assists in the remineralization of tooth enamel, making it more resistant to the erosive effects of acids derived from dietary sugars. By integrating into the crystal structure of the tooth, it helps to slow the progression of early-stage cavities and can prevent new ones from forming.

Common Formulations

Endekay is available in several different formats to suit various patient needs and age groups:

  • Mouthwashes: Liquid solutions designed for rinsing the oral cavity, often used daily or weekly to provide a consistent layer of fluoride protection.
  • Fluoride Tablets: Oral supplements that are dissolved in the mouth, typically used in areas where the water supply is not fluoridated to ensure adequate mineral intake for developing teeth.
  • Fluoride Drops: Concentrated liquid forms often intended for younger children to assist in the healthy development of permanent teeth before they emerge.

Mechanism of Action

Endekay works by increasing the concentration of fluoride in the saliva and the dental biofilm. When the pH in the mouth drops due to acid production, the presence of fluoride encourages the deposition of calcium and phosphate back into the enamel. This process, known as remineralization, results in a tooth surface that is physically harder and chemically more stable than the original enamel. Furthermore, fluoride can interfere with the metabolic processes of plaque bacteria, reducing their ability to produce the acids that lead to decay.

Regulatory References

  1. The Role of Fluoride on Caries Prevention - NCBI Bookshelf

What side effects are possible with Endekay?

The official safety information for this topical sodium fluoride preparation focuses primarily on adverse effects related to unintended systemic exposure, such as swallowing the rinse, rather than effects from correct topical application.

Adverse Reactions by System-Organ Class

The majority of documented adverse reactions relate to acute toxicity following accidental ingestion or chronic overexposure.

System-Organ Class Officially Documented Effects
Gastrointestinal Disorders Nausea, vomiting, diarrhea, stomach cramps, and increased salivation are noted following ingestion, typically occurring within 30 minutes.
Dental and Oral Dental Fluorosis (discoloration or white streaks on teeth) is the primary long-term effect of concern, resulting from prolonged daily ingestion during tooth development. Local mouth irritation or sore tongue may occur.
Immune System Disorders Hypersensitivity reactions (allergic reactions) are documented in regulatory sources but are rarely reported events.
Nervous System Disorders Drowsiness, tremors, or weakness may occur in cases of severe acute toxicity (overdose).

Serious Adverse Reactions and Safety Constraints

The most clinically significant adverse reactions are associated with a large accidental overdose. These include signs of severe systemic toxicity, such as bloody vomit, shallow breathing, convulsions, and severe abdominal pain.

Use is contraindicated in patients with a known hypersensitivity to any ingredient in the formulation. Furthermore, regulatory documents advise against use in individuals who have difficulty swallowing (dysphagia) to prevent systemic exposure to the preparation.

Population-Specific Safety Considerations

A key safety constraint is applied to Pediatric Patients. Use is often restricted or cautioned in children under six years of age because they frequently cannot perform the rinsing process without accidentally swallowing the solution. This risk of chronic ingestion is directly linked to the development of Dental Fluorosis during their tooth formation period. Caution is also advised for patients with severe kidney impairment, as their ability to excrete fluoride may be compromised, increasing the risk of systemic accumulation.

Overdose and Emergency Response

The official regulatory profile for an overdose of this topical fluoride preparation is defined by the acute systemic response following accidental ingestion of a large volume. Documented manifestations commonly begin with significant gastrointestinal distress, including nausea, vomiting, abdominal pain, and diarrhea. Other initial signs listed in official labeling include tremors, weakness, and excessive salivation.

Immediate action is critically mandated when accidental ingestion exceeds the typical dose. Due to the rapid systemic potential, official guidance requires the user to seek immediate medical attention or contact a Poison Control Center right away.

In cases of massive acute ingestion, the regulatory documents cite the risk of severe, life-threatening outcomes. These can include profound electrolyte derangement, specifically severe hypocalcaemia (low serum calcium), which can lead to complications such as convulsions, arrhythmias, and ultimately, respiratory failure. The threshold for initiating immediate therapeutic intervention, known as the Probably Toxic Dose (PTD), is cited as 5 mg of fluoride per kilogram of body weight. Because of the flavoring, the pediatric population is noted in regulatory warnings as being at high risk for accidental overdose. Management in a healthcare setting involves supportive and symptomatic treatment, including monitoring serum calcium and continuous cardiac observation.

Therapeutic Uses of Endekay

What Endekay Treats: Main Uses and Benefits

Endekay is applied across domains where additional symptomatic support is needed for oral health. The preparation is relevant in contexts marked by increased discomfort or tension, associated with dental caries (tooth decay) and tooth hypersensitivity.

Endekay is used for managing situations involving conditions where teeth are vulnerable to acid attacks, and may assist with managing the process of demineralization in its early stages. This supportive action may be part of symptomatic management for symptoms related to physical discomfort often experienced in response to cold or hot stimuli, contributes to improved comfort during periods of heightened symptoms, and supports patients during difficult episodes by easing distress. The primary focus is managing conditions presenting with systemic or localized discomfort; this is commonly used to help with managing tooth decay risk, easing hypersensitivity, and supporting specific patient groups, such as those with orthodontic braces or reduced saliva flow.


Quick Fact: Relief for Caries Risk
Primary Focus Managing symptoms associated with acute or episodic changes relevant to caries risk.
Symptom Relevance Is relevant for easing symptoms related to physical discomfort, commonly seen when enamel is compromised.
Typical Context Is relevant for easing discomfort in clinical settings that involve acute or unstable symptom patterns for specific patient groups.

Regulatory References

  1. World Health Organization (WHO) expert review

Eligibility and Restrictions for Use

Official Regulatory Eligibility for Endekay

The eligibility for Endekay mouthrinse is strictly defined by regulatory documents, focusing primarily on age and known ingredient sensitivity.

Eligibility Status Defined Populations
Allowed for Use Adults and children six years of age and older are eligible for standard, labeled use.
Contraindicated Individuals with known hypersensitivity to sodium fluoride or any excipient in the product, and patients with conditions like dysphagia (difficulty swallowing).

Age-Related Eligibility: Children under six years old are generally not recommended for use. This restriction is documented to minimize the risk of accidental swallowing and the potential for dental fluorosis from systemic fluoride overexposure. Children under the age of 12 are subject to instructions regarding supervision during use to ensure proper rinsing habits.

Conditional Use Considerations:

  • Pregnancy: The product holds a Pregnancy Category B classification, meaning use is permitted when the clinical need is established.
  • Lactation: Caution is advised due to the absence of specific human data on excretion into breast milk.
  • Health Conditions: Patients with severe kidney problems or a history of stomach ulcers should exercise caution due to the systemic retention and potential exacerbation of these conditions by fluoride intake.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Official regulatory information for Endekay, which contains sodium fluoride, indicates a limited and generally low-risk interaction profile. Based on official labeling and periodic safety reviews, no clinically significant drug-drug interactions have been systematically reported or established for this product.

However, the presence of fluoride in Endekay necessitates attention to certain substance categories, primarily to optimize the absorption and effect of the fluoride itself.

  • Medicinal Products and Supplements: To ensure the full benefit of the fluoride component, official guidance recommends separating the administration of Endekay from calcium supplements and aluminum hydroxide-containing products (such as certain antacids). These substances can bind to fluoride in the digestive tract, potentially reducing its overall absorption into the body. It is generally advised to space the doses of Endekay and these interacting products by at least two hours.
  • Food and Drink: The interaction profile of sodium fluoride also includes a timing condition regarding consumption. It is recommended to avoid eating or drinking for a short time after using the product. While this is primarily an administration note to maximize topical tooth exposure, it is considered a procedural constraint related to product efficacy.

Overall, official regulatory documents state that no drug interactions are known for Endekay, with the main constraint being the temporal separation from products that may chelate or bind to fluoride.

Mechanism of Action

The mechanism of action for Endekay, based on Sodium Fluoride, involves two primary mechanistic domains: modification of the tooth structure and modulation of oral microbial processes.

Modifying Dental Mineral Structure

This domain covers the direct chemical interaction with the tooth surface. The fluoride ion ( F^-) is incorporated into the hydroxyapatite crystal of the enamel and dentine, replacing the native hydroxyl ion ( OH^-) to form fluorhydroxyapatite. This structural substitution results in a crystal that exhibits reduced solubility in the presence of acid, altering the chemical environment for mineral maintenance.

Suppressing Bacterial Acid Production

This mechanism focuses on interfering with the metabolism of the bacteria in the mouth. Fluoride ions enter acid-producing oral bacteria and inhibit key metabolic enzymes within the glycolytic pathway, such as enolase, which are essential for converting sugars into corrosive acids (acidogenesis). By limiting this acid production, the mechanism leads to a localized higher pH at the tooth surface, which chemically favors the stability of the dental mineral.

Dosage and Administration Information

The application of Endekay involves a process focusing on topical oromucosal application to the teeth. The solution, which contains 0.05% w/v of Sodium Fluoride, is intended for once daily use as an integrated part of a daily oral hygiene routine. This preparation is formulated to be swished in the mouth and must always be expectorated (spit out), defining the route as local and strictly non-systemic.

The daily regimen requires using a measured volume of 10 mL of the solution. The schedule involves using the solution after the teeth have been brushed and swishing it vigorously between the teeth for a duration of 1 minute. A constraint on oral intake is also specified: users should refrain from eating or drinking for 30 minutes immediately after rinsing.

Use is limited to adults and children 6 years of age and older, reflecting the age threshold for use. Procedural guidance involves ensuring that children under 12 years are supervised during the rinsing process to confirm the solution is used correctly. This daily process describes the overall administration of the product to ensure consistent application.

Recent Clinical Evidence

Research evidence / Overview of Studies for Endekay

This section provides a summary of the official clinical research evidence for the active ingredient, sodium fluoride mouthrinse, focusing on what studies were conducted, what they examined, and what major findings were reported by regulatory and scientific sources.


Evidence for the Prevention and Control of Dental Caries

Research evidence primarily explored contexts related to the prevention and control of dental caries (tooth decay). This research relied on Randomized Controlled Trials (RCTs) and Systematic Reviews, which focused on measuring the difference in new carious lesions over defined time intervals, using indices like the DMFT/DMFS score.

Findings indicate patterns where individuals using the fluoride mouthrinse were associated with lower measurements of new carious lesions compared to control groups. High-certainty evidence for this pattern is most available from studies focused on children and adolescents and often involved supervised application.

The majority of high-certainty evidence comes from studies focused on supervised settings, meaning the results apply only to the populations studied and may not perfectly reflect unsupervised use at home. Comparative evidence is lacking regarding the precise added contribution of the rinse when used by individuals already utilizing fluoride from other common sources.


Research on Dentin Hypersensitivity Management

Research has explored the use of the preparation in managing symptoms related to physical discomfort associated with exposed dentin surfaces. Trials were typically small-scale and short-term, measuring patient-reported discomfort.

In these studies, sensitivity scores were often similarly reduced in both the active rinse group and the placebo group. Because of the substantial response observed in control groups, the evidence quality for the mouthrinse formulation alone is currently considered Low. The specific contribution of the fluoride rinse is challenging to characterize in this context.


Evidence Gaps and Areas of Uncertainty

Evidence for the rinse is most extensive for children and adolescents and in the context of caries prevention. However, data for certain groups remain insufficient, and the long-term effects are not fully established for regular, unsupervised use started in adulthood. The primary limitation across the evidence base is the difficulty in determining the added contribution the rinse provides when an individual is already using fluoride from other sources.

Key Studies & References WHO Expert Committee on the Selection and Use of Essential Medicines: Application for new formulations/strengths of existing listed medicines (Fluoride Mouthrinse)

Frequently Asked Questions (FAQ)

Common questions about Endekay (FAQ)

Q: What are the most commonly reported mild side effects of Endekay?

A: According to regulatory documents, when Endekay is used correctly, the most common reported reactions are mild irritation of the mouth or gums. Other symptoms such as nausea, vomiting, or stomach cramps have been documented primarily in cases where the product was accidentally swallowed.


Q: Is Endekay safe to use with supplements or vitamins?

A: Official regulatory guidance describes the need for temporal separation between using Endekay and taking calcium supplements or products containing aluminum hydroxide, such as certain antacids. This measure is described as preventing these substances from binding to the fluoride and potentially reducing its full benefit. A separation of at least two hours is noted in official documents.


Q: Is Endekay safe for use by older adults?

A: Official regulatory documents indicate that the product is approved for use by adults, which includes the elderly population, from six years of age and older. No specific restrictions or warnings that apply only to older adults are typically noted in the official prescribing information.


Q: Can people with kidney or liver conditions use Endekay?

A: The official product information specifies the need for caution for patients with severe kidney impairment due to a potential risk of fluoride accumulation in the body. However, regulatory documents typically do not contain specific warnings concerning liver conditions for this topical application product.


Q: Where can I find the official regulatory information about Endekay?

A: Authoritative information about this medicine is detailed in official regulatory sources. Patients may find this information in documents such as the Summary of Product Characteristics (SmPC) in the EU/UK, or the FDA Prescribing Information and DailyMed Label in the US.


Q: What evidence exists regarding the long-term safety of Endekay?

A: Long-term safety data primarily focuses on preventing chronic issues like Dental Fluorosis, which is a risk if the product is regularly ingested during the tooth formation years. Official assessments of the product have also examined potential risks, such as carcinogenicity, which regulatory findings currently indicate is not credibly linked to use.


Q: Does the effectiveness of Endekay vary by age or gender?

A: Studies summarized in official documents indicate that the clinical evidence is most extensive for the prevention of dental caries in children and adolescents. The product information does not contain specific findings to suggest a variation in effectiveness based on gender.


Q: What does 'contraindication' mean in the context of Endekay?

A: A contraindication is an official reason to avoid using a medicine because it could potentially cause harm to the patient. For Endekay, official documents list contraindications such as a known hypersensitivity to any of the ingredients, and the presence of difficulty swallowing, also known as dysphagia.


Q: What should I look out for that might be an early sign of a serious side effect?

A: Official warnings describe symptoms of acute toxicity that may occur if the product is accidentally swallowed in large amounts. These symptoms can include an acute burning sensation in the mouth, immediate nausea, vomiting, or severe stomach pain. Should these signs occur, they are considered situations warranting prompt medical review.


Q: Can Endekay be used during the day or only at night?

A: The product is indicated for 'once daily' use as an integrated part of a regular oral hygiene routine. Official guidance provides flexibility, meaning it can generally be incorporated into the routine either in the morning or at night.


Q: Is it common to feel tired when starting Endekay?

A: According to official product information, drowsiness or general weakness are not listed among the commonly reported side effects from the correct use of the rinse. These symptoms are instead associated with the signs of severe acute toxicity that can occur following an accidental overdose.


Q: Can Endekay be taken with common pain relievers like ibuprofen?

A: Official regulatory documents state that no clinically significant drug-drug interactions are known for this topical mouthrinse. This general finding extends to common over-the-counter pain relievers.


Q: Does Endekay require a gradual increase or decrease when starting or stopping?

A: The product is designed to be used once daily at a standardized volume. Official regulatory information does not mention a requirement for a gradual increase or decrease in the amount used when beginning or discontinuing the rinse.


Q: Are there any official warnings about driving or operating machinery while taking Endekay?

A: Official regulatory warnings for this topical product do not typically include any restrictions or cautions regarding driving or operating machinery when the product is used as directed.


Q: What if I experience a mild headache after starting Endekay—is that normal?

A: Headache is not listed among the documented side effects associated with the correct use of Endekay mouthrinse. This symptom has been noted in regulatory documents as potentially occurring in cases of accidental overdose.


Q: Does Endekay interact with alcohol, and what does official guidance say?

A: Official product labeling and regulatory information do not typically list specific interactions with alcohol for this topical sodium fluoride mouthrinse.


Q: Is Endekay known to cause any skin reactions?

A: Official adverse reaction profiles mention that hypersensitivity (allergic) reactions are rarely reported. These reactions may potentially include symptoms such as a skin rash or itching.


Q: What are the main ingredients in Endekay besides the active component?

A: The product is composed of the active ingredient, Sodium Fluoride, and other components known as excipients. These excipients are listed in the regulatory label and typically include purified water, flavorings, and other substances designed to ensure the product's stability and taste.


Q: How is Endekay generally eliminated from the body?

A: When the product is accidentally ingested, any unabsorbed fluoride is generally eliminated through feces. Fluoride that is absorbed into the body is primarily excreted through the urinary system, as described in clinical pharmacology information.


Q: Why is this medicine sometimes referred to by a different name?

A: This medicine may sometimes be referred to by its generic chemical name, which is Sodium Fluoride, or by other authorized brand names that contain the same active ingredient. These different names are used depending on the official market or context.


Q: Are there any specific lifestyle changes recommended alongside Endekay?

A: Official product information describes that the rinse is used as an integrated part of a daily oral hygiene routine. A key procedural constraint is the requirement noted in the label to refrain from eating or drinking for 30 minutes immediately following the use of the product.


Q: What common over-the-counter cold and flu medicines interact with Endekay?

A: Official regulatory documents state that no clinically significant drug-drug interactions have been established for this topical mouthrinse. This finding generally includes common over-the-counter cold and flu preparations.


Q: Can I buy Endekay without a prescription in some places?

A: The legal status of the product is determined by the regulatory body in each region. In many areas, this specific concentration of sodium fluoride rinse is officially classified as an Over-The-Counter (OTC) medicine and is available without a prescription.


Q: What is the role of the inactive ingredients in Endekay?

A: Inactive ingredients, or excipients, are included in the formulation to help maintain the solution's stability, consistency, and palatability, often through the inclusion of flavorings and preservatives. They do not contribute to the primary medical action of the product.


Q: Is Endekay physically addictive or habit-forming?

A: Regulatory documents do not classify this product as a controlled substance. Consequently, official product information does not include warnings related to physical addiction or habit-forming potential.

How should Endekay be stored and disposed of?

The storage and disposal of Endekay mouthrinse must adhere strictly to the conditions specified in the official regulatory labeling to ensure product stability and household safety.

Storage Conditions

Requirement Official Regulatory Statement
Environment Must be kept in a cool, dry place, protected from excessive heat and light.
Child Safety Store strictly out of the sight and reach of children.
Stability Limit The bottle must be thrown away one month after opening.
Shelf-Life Do not use the medicine past the expiry date printed on the label.

Disposal Instructions

Unused, expired, or opened product must be discarded responsibly. For final disposal, users should consult local authorities for proper disposal guidelines for pharmaceutical waste. General chemical precautions indicate that the product should not be released into the environment or flushed into the sanitary sewer system to avoid contamination.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Endekay found in:

A-Z Index: